1. Market Research
  2. > Pharmaceutical
  3. > Therapy
  4. > Oncology Market Trends
  5. > Oncology Industry in European Union Market Research & Statistics

Oncology Industry in European Union Market Research & Statistics

Customer Support

Talk to Sam

+1 646 893 5945

All regions

31 reports

Download Unlimited Documents from Trusted Public Sources

View report >

Targeted Therapy Market in EU

  • June 2019
  • 7 pages
  • Oncology
  • European Union
  • Statistics
  • Janssen Biotech, Inc.
  • Johnson & Johnson
View report >

Therapy Market

  • June 2019
  • 7 pages
  • Oncology
  • Therapy
  • European Union
  • Janssen Biotech, Inc.
  • Johnson & Johnson
View report >

Monoclonal Antibody Industry in EU

  • January 2019
  • 6 pages
  • Medical Biotechnology
  • Monoclonal Antibody
  • Oncology
  • European Union
  • Celltrion, Inc.
View report >

Global Biosimilar Demand Forecast Statistics

  • January 2019
  • 27 pages
  • Oncology
  • European Union
  • AbbVie Inc.
  • Amgen Inc.
  • Celltrion, Inc.
View report >

Biosimilar Industry in EU

  • January 2019
  • 10 pages
  • Biosimilar
  • Medical Biotechnology
  • Monoclonal Antibody
  • Oncology
  • European Union
View report >

Therapy Market and Targeted Therapy Market in EU

  • December 2018
  • 6 pages
  • Oncology
  • Therapy
  • European Union
  • Company
  • Janssen Biotech, Inc.
View report >

Global Therapy Market and Targeted Therapy Market

  • December 2018
  • 6 pages
  • Oncology
  • European Union
  • Company
  • Janssen Biotech, Inc.
  • Johnson & Johnson
View report >

Global Oncology Market

  • October 2018
  • 16 pages
  • Oncology
  • Therapy
  • European Union
  • Market Size
  • Price
View report >

Magnetic Resonance Imaging Demographic Impact in EU

  • August 2018
  • 26 pages
  • Chemotherapy
  • Digestive System Disorder
  • Magnetic Resonance Imaging
  • Oncology
  • European Union
View report >

Global Therapy Market

  • June 2018
  • 5 pages
  • Oncology
  • Therapy
  • European Union
  • World
  • Taiho Pharmaceutical Co., Ltd.

Search in Oncology Industry (31 reports)
Parent industry: Therapy

62 reports

Purchase Reports From Reputable Market Research Publishers

CB-839

  • $ 10000
  • March 2019
  • 14 pages

Drug OverviewCancer cells are known to rely on glycolysis as an energy source. CB-839 (Calithera Biosciences) inhibits the glutaminase enzyme, reducing the ability of cancer cells to utilize glutamine ...

  • Cancer
  • Oncology
  • Renal Cancer
  • European Union
  • Market Description

Aliqopa $ 10000 January 2019

Arzerra $ 10000 January 2019

Gazyva $ 10000 January 2019

polatuzumab vedotin $ 10000 October 2018

MOR208 $ 10000 October 2018

MEDI8897 $ 10000 October 2018

Alunbrig $ 10000 August 2018

Portrazza $ 10000 August 2018


Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on